Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN107,9108,2-1,92
Msft-0,13
Nokia5,8665,921,16
IBM1,10
Mercedes-Benz Group AG57,5857,60,89
PFE0,40
14.02.2026 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 13.02.2026
CV Sciences (US Other OTC (Pink Sheets))
Závěr k 13.2.2026 Změna (%) Změna (USD) Objem obchodů (ks)
0,05088 20,24 0,01 1 679 600
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 15.02.2026
Popis společnosti
Obecné informace
Název společnostiCV Sciences Inc
TickerCVSI
Kmenové akcie:Ordinary Shares
RICCVSI.PK
ISIN-
Prioritní akciePreference Shares
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky30.09.2025
Počet zaměstnanců k 31.12.2024 47
Akcie v oběhu k 30.09.2025 184 264 000
MěnaUSD
Kontaktní informace
Ulice9530 PADGETT STREET, SUITE 107
MěstoSAN DIEGO
PSČ92126
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Fax16198764321

Business Summary: CV Sciences, Inc. is a consumer wellness company specializing in nutraceuticals and plant-based foods. The Company develops, manufactures, markets and sells herbal supplements, CBD products and plant-based food products under +PlusCBD, +PlusHLTH, Cultured Foods, and Lunar Fox brands in the healthcare market sector, including nutraceutical, beauty care, specialty foods, and pet products. Its hemp extracts, and other science-backed, natural ingredients and products are sold through a range of sales channels from business-to-business (B2B) to business-to-consumer (B2C). Its +PlusCBD line of products are available in softgels, tinctures, topicals, and gummies. Its Cultured Foods and Lunar Fox cater to individuals seeking vegan, gluten-free, or flexitarian options for a nutritious and satisfying culinary experience. Its +PlusHLTH is a line of cannabinoid-free supplements delivering targeted formulations for optimized health, improved performance and increased vitality.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, CV Sciences Inc revenues decreased 11% to $10.5M. Net loss decreased 55% to $752K. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects United States segment loss decrease of 59% to $395K.
Odvětvová klasifikace
TRBC2012Pharmaceuticals (NEC)
RBSS2004Food Processing
MGINDUSTRYBiotechnology & Drugs
MGSECTORHealthcare
NAICSMedicinal and Botanical Manufacturing
NAICSPharmaceutical Preparation Manufacturing
NAICS2007Medicinal & Botanical Mfg
NAICS2007Pharmaceutical Preparation Mfg
NAICS1997Medicinal and Botanical Manufacturing
NAICS1997Pharmaceutical Preparation Manufacturing
SICReal Estate Agents And Managers
SICMedicinals And Botanicals
SICPharmaceutical Preparations
SICMisc Food Stores
SICDrug Stores/proprietary Stores
SICMisc Personal Services, Nec
SICCommercial Physical Research



  • Poslední aktualizace: 15.02.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chief Executive Officer, Secretary, DirectorJoseph Dowling6715.03.201916.06.2014
Chief Financial OfficerJoerg Grasser5015.03.201915.03.2019